Evidence map›Paper›PMID 37629242›Full record

ArticleJournal of clinical medicine2023

Safety of Citrate Anticoagulation in CKRT: Monocentric Experience of a Dynamic Protocol of Calcium Monitoring.

Federico Nalesso, Elisabetta Bettin, Marco Bogo, Martina Cacciapuoti, Leda Cattarin, Giuseppe Scaparrotta, Lorenzo A Calò

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Federico NalessoDepartment of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy.ORCID 0000-0002-1167-2764
Elisabetta BettinDepartment of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy.
Marco BogoDepartment of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy.
Martina CacciapuotiDepartment of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy.ORCID 0000-0002-6518-1362
Leda CattarinDepartment of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy.
Giuseppe ScaparrottaDepartment of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy.
Lorenzo A CalòDepartment of Medicine, Nephrology, Dialysis and Transplant, University of Padua, 35128 Padua, Italy.ORCID 0000-0002-7534-0128
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regional Citrate Anticoagulation (RCA) is considered the first-line anticoagulation for Continuous Kidney Replacement Therapy (CKRT). The RCA requires strict protocols and trained staff to avoid unsafe use and ensure its benefit. We have analyzed all our CKRT prescriptions from December 2020 to April 2022 anonymously, collecting data on CKRT, lab tests, clinical conditions, and complications of RCA. In addition, in order to better detect citrate accumulation, we have performed an RCA protocol by reducing the Ca

Indexed as

AKIanticoagulation protocolblood calciumCKRTcritical Ill patientregional citrate anticoagulation

Identifiers

PMID37629242
PMCPMC10455350
OpenAlexW4385741586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.